Confusion
18
2
3
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.6%
1 terminated out of 18 trials
87.5%
+1.0% vs benchmark
11%
2 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (18)
Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients
Validation of a French Version of the Confusion Assessment Method (CAM)
Intelligent Intensive Care Unit
Pervasive Sensing and AI in Intelligent ICU
Improving Safety of Diagnosis and Therapy in the Inpatient Setting
Study of Melatonin on Sleep, Pain, and Confusion After Joint Replacement Surgery
Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN)
A Software to Prevent Delirium (PREVEDEL) in Hospitalized Older Adults
Efficacy of a Transcranial Vibrating System for Mitigation of Migraine Associated Vertigo
Hypnosis Versus SIVOC by Remifentanil During TAVI Procedures : Iloact on Peripoperative Confusion
Evaluation of Decision Capacity of ICU Patients Under Sedatives. A Prospective Observational Multicenter Study.
Transcranial Direct Current Stimulation for the Treatment of Delirium
Dexmedetomidine for the Treatment of Delirium After Heart Surgery
Trial of a Medical and Mental Health Unit for Older People
Ketamine Challenge Study With JNJ-40411813
Inadequate Emergence After Laparoscopic Surgery in Trendelemburg Position
Dynamic Light Application to Prevent ICU Acquired Delirium
Confusion in the Elderly After Colon Surgery